Sebastian Bunk

This inventor holds 38 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in T Cell Receptors. Top assignees: Immatics Biotechnologies Gmbh, Emmatics Biotechmiogieg Gmbh. Active years: 2020-2026.

USPTO Granted Patents = 38 (Patent Applications = 26)

% Patents Active = 84.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 20)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Tübingen, DE (2020 - 2024)
Tuebingen, DE (2020 - 2024)

Company Filing History:

37 out of 728

Immatics Biotechnologies Gmbh

patents

1 out of 1

Emmatics Biotechmiogieg Gmbh

patent

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

T Cell Receptors

Immunotherapy

Antigen Binding Proteins

Peptide-MHC Binding

Cancer Treatment

Transfected T-cells

Dual Specificity Polypeptide

Affinity Screening

Engineered T Cell Receptors

PRAME

MAGE-A

CT45

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570760 - Antigen binding proteins specifically binding PRAME (2026-03-10),

2. 12480958 - METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES (2025-11-25),

3. 12297252 - T cell receptors with improved pairing (2025-05-13),

4. 12269881 - Antigen binding proteins specifically binding MAGE-A (2025-04-08),

5. 12209137 - Antigen binding proteins specifically binding CT45 (2025-01-28),

6. 12188932 - Method for high throughput peptide-MHC affinity screening for TCR ligands (2025-01-07),

7. 12162940 - BMA031 antigen binding polypeptides (2024-12-10),

8. 11998607 - T cell receptors and immune therapy using the same (2024-06-04),

9. 11945854 - Transfected T-cells and T-cell receptors for use in immunotherapy against cancers (2024-04-02),

10. 11939376 - T cell receptors and immune therapy using the same (2024-03-26),

11. 11932689 - Engineered T cell receptors and immune therapy using the same (2024-03-19),

12. 11905328 - Dual specificity polypeptide molecule (2024-02-20),

13. 11859009 - Antigen binding proteins specifically binding PRAME (2024-01-02),

14. 11840577 - Antigen binding proteins specifically binding MAGE-A (2023-12-12),

15. 11730796 - Transfected t-cells and t-cell receptors for use in immunotherapy against cancers (2023-08-22),

Title: The Innovative Mind of Sebastian Bunk

Introduction: Sebastian Bunk, a talented inventor hailing from Tuebingen, Germany, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sebastian Bunk's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar power systems that are more efficient and cost-effective.

Career Highlights: With a career spanning over two decades, Sebastian Bunk has established himself as a leading figure in the renewable energy sector. His innovative solutions have not only revolutionized the industry but have also paved the way for a more sustainable future.

Collaborations: Throughout his career, Sebastian Bunk has collaborated with top research institutions and leading companies in the energy sector to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into reality.

Conclusion: Sebastian Bunk's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the field of renewable energy. His contributions continue to inspire the next generation of inventors and shape the future of sustainable technology.